Elkhorn Investments LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,429 shares of the company’s stock after buying an additional 743 shares during the period. Elkhorn Investments LLC’s holdings in Colgate-Palmolive were worth $1,246,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of CL. Point72 Asset Management L.P. acquired a new position in shares of Colgate-Palmolive in the third quarter worth about $1,814,000. The Manufacturers Life Insurance Company lifted its stake in shares of Colgate-Palmolive by 10.3% in the second quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after acquiring an additional 105,878 shares in the last quarter. Pensionfund DSM Netherlands acquired a new position in shares of Colgate-Palmolive in the third quarter worth about $4,225,000. Pictet & Cie Europe SA lifted its stake in shares of Colgate-Palmolive by 5.5% in the third quarter. Pictet & Cie Europe SA now owns 123,000 shares of the company’s stock worth $8,961,000 after acquiring an additional 6,400 shares in the last quarter. Finally, Roosevelt Investment Group Inc. acquired a new position in shares of Colgate-Palmolive in the second quarter worth about $1,044,000. 73.87% of the stock is owned by institutional investors.
Shares of Colgate-Palmolive (NYSE CL) traded down $0.14 during midday trading on Wednesday, reaching $70.73. The company’s stock had a trading volume of 224,818 shares, compared to its average volume of 3,965,597. Colgate-Palmolive has a 12-month low of $68.19 and a 12-month high of $77.91. The firm has a market capitalization of $62,218.23, a PE ratio of 31.08, a P/E/G ratio of 2.63 and a beta of 0.79. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be paid a dividend of $0.42 per share. The ex-dividend date is Thursday, April 19th. This represents a $1.68 annualized dividend and a yield of 2.38%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
CL has been the topic of several recent analyst reports. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research note on Monday, January 8th. Deutsche Bank initiated coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price target on the stock. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Jefferies Group reiterated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 26th. Finally, Citigroup boosted their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $77.91.
In other news, insider Jennifer Daniels sold 902 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the sale, the insider now directly owns 37,788 shares in the company, valued at approximately $2,865,086.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Noel R. Wallace sold 126,304 shares of the stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the sale, the chief operating officer now owns 305,631 shares in the company, valued at $22,549,455.18. The disclosure for this sale can be found here. Insiders have sold 455,707 shares of company stock worth $32,443,427 in the last 90 days. 1.02% of the stock is currently owned by insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.